Pulmonx Corporation LUNG
2.69 USD -0.04 (-1.65%)
Regular-session close
2.40 -0.29 -10.78%
Pre-market · Nov 19, 4:00 AM ET
2.67 Day range 2.89
1.13 52-week range 3.25
- YTD
- +21.72%
- 1 year
- +92.14%
News
globenewswire.com Pulmonx to Participate in the Piper Sandler 38th Annual Healthcare Conference REDWOOD CITY, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the…benzinga.com Pulmonx Announces Online Publication Of Results From CONVERT Trial Evaluating AeriSeal System In Patients With Severe Emphysema And Collateral Ventilation Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), today announced the online…
globenewswire.com Pulmonx Announces Publication of CONVERT Trial Results for AeriSeal® System Pulmonx® announced the publication of CONVERT Trial results evaluating the AeriSeal® System in patients with severe emphysema and collateral ventilation.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Pulmonx (NASDAQ:LUNG) stock increased by 33.1% to $2.63 during Wednesday's regular session. The company's market cap stands at $85.0 million. As per the press release, Q3 earnings came out…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…
benzinga.com Pulmonx Q3 2026 Earnings Call Transcript Pulmonx (NASDAQ:LUNG) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Neumora Therapeutics (NASDAQ:NMRA) shares rose 11.9% to $0.41 during Tuesday's after-market session. The market value of their outstanding shares is at $73.8 million. Pulmonx (NASDAQ:LUNG)…benzinga.com Pulmonx Q3 EPS $(0.19) Beats $(0.26) Estimate, Sales $22.835M Beat $21.944M Estimate Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) by 26.92 percent. This is a 44.12 percent increase over losses of $(0.34) per…
benzinga.com Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.608M Est Pulmonx (NASDAQ:LUNG) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.608 million estimate.
